Tonix Pharmaceuticals Holding Corp. Logo

Tonix Pharmaceuticals Holding Corp.

Develops therapies and vaccines for complex conditions and public health challenges.

TNXP | US

Overview

Corporate Details

ISIN(s):
US8902608392
LEI:
Country:
United States of America
Address:
26 MAIN STREET, SUITE 101, 7928 CHATHAM
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that develops therapies and vaccines for complex, chronic conditions and public health challenges. The company's pipeline is focused on four main therapeutic areas: Central Nervous System (CNS) disorders, immunology, infectious diseases, and rare diseases. Key development programs include treatments for acute stress disorder, organ transplant rejection, Prader-Willi syndrome, and various cancers. Tonix also utilizes an in-house live virus vaccine platform to develop biodefense countermeasures against pathogens such as mpox and smallpox. The company's approach is centered on addressing unmet medical needs through scientific development of its portfolio of investigational product candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Tonix Pharmaceuticals Holding Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Tonix Pharmaceuticals Holding Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Tonix Pharmaceuticals Holding Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

DBV Technologies S.A. Logo
Developing non-invasive skin patch immunotherapies for food allergies and immune diseases.
United States of America
DBVT
D&D Pharmatech Inc. Logo
Develops oral & injectable peptide therapies for metabolic & chronic diseases like obesity.
South Korea
347850
Dechra Pharmaceuticals PLC Logo
Develops & sells veterinary pharmaceuticals for companion animals, exclusively to veterinarians.
United Kingdom
DPH
Denali Therapeutics Inc. Logo
Developing therapies for neurodegenerative diseases that cross the blood-brain barrier.
United States of America
DNLI
Dermapharm Holding SE Logo
Manufactures patent-free branded pharmaceuticals & healthcare products for niche markets.
Germany
DMP
Dermata Therapeutics, Inc. Logo
Develops OTC skin treatments using a unique delivery technology from freshwater sponges.
United States of America
DRMA
Design Therapeutics, Inc. Logo
Develops small molecule genomic medicines to treat serious genetic diseases by modulating genes.
United States of America
DSGN
Deutsche Biotech Innovativ AG Logo
Develops biomarker-driven therapeutics and diagnostics for serious diseases with unmet needs.
Germany
DBI
DEVA HOLDİNG A.Ş. Logo
Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.
Spain
DEVA
Devyser Diagnostics Logo
Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.
Sweden
DVYSR

Talk to a Data Expert

Have a question? We'll get back to you promptly.